PEN

#702
Penumbra, Inc. Common Stock
318.3 0 USD
-0.41%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
318.23
318.82
Rango anual
3.19
362.41
Cambio diario
-0.41%
Variación mensual
-2.26%
Variación en los últimos 6 meses
+7.67%
Cambio anual
+22.42%
Cierres anteriores
319.6 0
Open
318.3 5
Mínimo
318.2 3
High
318.8 2
Volumen
525
Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 12.52 B
  • Employee 4 700
  • Founded 2004
  • CEO Adam Elsesser
  • Website www.penumbrainc.com
  • Headquarter Delaware, United States
  • FIGI BBG001BP92V1
  • Industry Aparatos médicos
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
75.66
Relación precio/flujo de caja
8.88

Penumbra, Inc. Common Stock

Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm. In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by yearend.

Noticias